Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Bahija Jallal
Age : 59
Public asset : 1,743,382 USD
Linked companies : Anthem, Inc. - Guardant Health, Inc. - Immunocore Holdings plc
Summary 
Dr. Bahija Jallal is an Independent Director at Guardant Health, Inc., a Chief Executive Officer & Director at Immunocore Holdings Plc, an Independent Director at Anthem, Inc., a Chief Executive Officer & Director at Immunocore Ltd. and a Council Member at National Academies of Sciences.

She is on the Board of Directors at Arrivent Biopharma, Inc., Guardant Health, Inc., Immunocore Holdings Plc, Anthem, Inc., Immunocore Ltd., Umb Health Sciences Research Park Corp. and The Johns Hopkins University. Dr. Jallal was previously employed as a President by Association for Women in Science, an Executive Vice President by AstraZeneca Plc, a President by MedImmune LLC, a Vice President-Drug Assessment & Development by Chiron Corp., and a Non-Executive Director by ADC Therapeutics SA.

She also served on the board at Viela Bio, Inc.


Current positions of Bahija Jallal 
NameTitle Since
Anthem, Inc.
(Managed Healthcare)
Independent Director 2018
Guardant Health, Inc.
(Biotechnology & Medical Research)
Independent Director 2019
Immunocore Holdings plc
(Biotechnology & Medical Research)
Chief Executive Officer & Director 2019
The Johns Hopkins University Trustee -
Umb Health Sciences Research Park Corp. Director -
Arrivent Biopharma, Inc. Director 2022
Immunocore Ltd. Chief Executive Officer & Director -
National Academies of Sciences Council Member -


Holdings of Bahija Jallal 
NameEquities%Valuation
Anthem, Inc. (ANTM)
(Managed Healthcare)
2,9020.0012%1,456,601 USD
Guardant Health, Inc. (GH)
(Biotechnology & Medical Research)
4,6480.0046%286,782 USD
Immunocore Holdings Plc00.0000%0 USD


Bahija Jallal: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/02ELON MUSK : Musk seeks to put in less money in new Twitter deal financing -sources
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/03Stocks rise, U.S. yields slip as markets await Fed rate hike
RE
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
RE
05/03ELON MUSK : Elon Musk plans to take Twitter public again later - WSJ
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
More news


© 2022 People and Ownership :   
Bahija Jallal : Connections